Hale International(uk) Limited

POWER SEARCH PRICING

SOLUTIONS

hale international(uk) limited Company Information

Live

EstablishedMicroLow

Company Number

07011593

Next Accounts

Jan 2026

Industry

Dispensing chemist in specialised stores

Directors

Jayvin Patel

Shree Patel

Shareholders

sj pharmacare ltd

Group Structure

View All

Contact

Registered Address

hillingdon house, 386-388 kenton road, harrow, middlesex, HA3 9DP

Website

aspenpharma.com

hale international(uk) limited Estimated Valuation

£164.8k

Pomanda estimates the enterprise value of HALE INTERNATIONAL(UK) LIMITED at £164.8k based on an EBITDA of £47.6k and a 3.46x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Hale International(uk) Limited is a live company located in harrow, HA3 9DP with a Companies House number of 07011593. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in September 2009, it's largest shareholder is sj pharmacare ltd with a 100% stake. Hale International(uk) Limited is a established, micro sized company, Pomanda has estimated its turnover at £211.7k with low growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Hale International(Uk) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating3.5out of 5

2 Strong

4 Regular

6 Weak

Size

annual sales of £211.7k, make it smaller than the average company (£13.9m)

Growth

3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (7.7%)

EXPORT

Hale International(Uk) Limited's latest turnover from April 2024 is estimated at £211.7 thousand and the company has net assets of £31.4 thousand. According to their latest financial statements, Hale International(Uk) Limited has 4 employees and maintains cash reserves of £58.2 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011
Turnover	211,651	218,088	198,740	208,326	198,635	384,250	458,489	468,066	444,186	465,135	468,754	623,011	479,769	424,588
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	154,456	157,108	142,280	151,175	149,026	285,003	334,605	336,445	321,868	341,620	337,085	451,366	353,503	314,876
Gross Profit	57,195	60,980	56,459	57,151	49,609	99,246	123,884	131,621	122,318	123,515	131,669	171,645	126,265	109,712
Admin Expenses	47,234	73,616	41,262	66,195	41,370	106,996	127,362	111,860	103,396	124,555	126,511	172,334	159,163	64,712
Operating Profit	9,961	-12,636	15,197	-9,044	8,239	-7,750	-3,478	19,761	18,922	-1,040	5,158	-689	-32,898	45,000
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	2,100	904	644	91	20	35	1	0	2	3	294	306	96	82
Pre-Tax Profit	12,061	-11,732	15,841	-8,953	8,259	-7,715	-3,477	19,762	18,924	-1,037	5,452	-383	-32,802	45,082
Tax	-3,015	0	-3,010	0	-1,569	0	0	-3,755	-3,785	0	-1,145	0	0	-11,721
Profit After Tax	9,046	-11,732	12,831	-8,953	6,690	-7,715	-3,477	16,007	15,139	-1,037	4,307	-383	-32,802	33,361
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	9,046	-11,732	12,831	-8,953	6,690	-7,715	-3,477	16,007	15,139	-1,037	4,307	-383	-32,802	33,361
Employee Costs	94,795	88,327	84,115	77,511	76,121	74,244	73,028	70,769	69,314	68,747	68,063	84,379	67,150	50,522
Number Of Employees	4	4	4	4	4	4	4	4	4	4	4	5	4	3
EBITDA*	47,627	25,325	53,684	319,849	47,807	30,741	-3,478	19,761	59,621	40,897	47,897	38,744	6,202	101,814

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011
Tangible Assets	13,064	14,245	16,348	19,085	20,674	16,364	12,670	484,309	19,795	24,744	27,954	14,736	13,397	16,516
Intangible Assets	218,222	253,972	289,722	325,472	361,222	396,972	432,722	0	504,222	539,972	575,722	611,472	647,222	682,972
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	231,286	268,217	306,070	344,557	381,896	413,336	445,392	484,309	524,017	564,716	603,676	626,208	660,619	699,488
Stock & work in progress	25,198	27,364	31,917	31,355	38,699	34,297	50,505	0	28,575	29,525	26,225	25,048	23,114	33,258
Trade Debtors	13,961	19,327	12,835	11,750	16,460	88,799	92,821	87,456	93,100	90,070	92,014	111,377	107,475	86,469
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	58,159	21,852	20,691	150,960	30,956	9,084	203	0	314	571	692	117,046	5,345	32,863
misc current assets	0	0	0	0	0	0	0	0	100	100	100	100	100	100
total current assets	97,318	68,543	65,443	194,065	86,115	132,180	143,529	87,456	122,089	120,266	119,031	253,571	136,034	152,690
total assets	328,604	336,760	371,513	538,622	468,011	545,516	588,921	571,765	646,106	684,982	722,707	879,779	796,653	852,178
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	26,103	14,621	14,941	46,785	13,493	80,893	164,323	99,920	146,087	157,771	154,199	276,069	156,149	143,204
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current liabilities	26,103	14,621	14,941	46,785	13,493	80,893	164,323	99,920	146,087	157,771	154,199	276,069	156,149	143,204
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	271,119	299,803	322,504	470,600	421,663	439,500	391,329	437,253	481,334	523,665	563,925	603,434	639,845	675,513
provisions	0	0	0	0	2,665	1,623	2,054	0	0	0	0	0	0	0
total long term liabilities	271,119	299,803	322,504	470,600	424,328	441,123	393,383	437,253	481,334	523,665	563,925	603,434	639,845	675,513
total liabilities	297,222	314,424	337,445	517,385	437,821	522,016	557,706	537,173	627,421	681,436	718,124	879,503	795,994	818,717
net assets	31,382	22,336	34,068	21,237	30,190	23,500	31,215	34,592	18,685	3,546	4,583	276	659	33,461
total shareholders funds	31,382	22,336	34,068	21,237	30,190	23,500	31,215	34,592	18,685	3,546	4,583	276	659	33,461

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	9,961	-12,636	15,197	-9,044	8,239	-7,750	-3,478	19,761	18,922	-1,040	5,158	-689	-32,898	45,000	0
Depreciation	1,916	2,211	2,737	3,421	3,818	2,741	0	0	4,949	6,187	6,989	3,683	3,350	3,605	0
Amortisation	35,750	35,750	35,750	325,472	35,750	35,750	0	0	35,750	35,750	35,750	35,750	35,750	53,209	0
Tax	-3,015	0	-3,010	0	-1,569	0	0	-3,755	-3,785	0	-1,145	0	0	-11,721	0
Stock	-2,166	-4,553	562	-7,344	4,402	-16,208	50,505	-28,575	-950	3,300	1,177	1,934	-10,144	33,258	0
Debtors	-5,366	6,492	1,085	-4,710	-72,339	-4,022	5,365	-5,644	3,030	-1,944	-19,363	3,902	21,006	86,469	0
Creditors	11,482	-320	-31,844	33,292	-67,400	-83,430	64,403	-46,167	-11,684	3,572	-121,870	119,920	12,945	143,204	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	-2,665	1,042	-431	2,054	0	0	0	0	0	0	0	0
Cash flow from operations	63,626	23,066	17,183	362,530	47,817	-32,890	7,109	4,058	42,072	43,113	-56,932	152,828	8,285	113,570	0
Investing Activities
capital expenditure	-735	-108	0	-291,554	-8,128	-6,435	38,917	39,708	0	-2,977	-20,207	-5,022	-231	-756,302	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-735	-108	0	-291,554	-8,128	-6,435	38,917	39,708	0	-2,977	-20,207	-5,022	-231	-756,302	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	-28,684	-22,701	-148,096	48,937	-17,837	48,171	-45,924	-44,081	-42,331	-40,260	-39,509	-36,411	-35,668	675,513	0
share issue	0	0	0	0	0	0	100	-100	0	0	0	0	0	100	0
interest	2,100	904	644	91	20	35	1	0	2	3	294	306	96	82	0
cash flow from financing	-26,584	-21,797	-147,452	49,028	-17,817	48,206	-45,823	-44,181	-42,329	-40,257	-39,215	-36,105	-35,572	675,695	0
cash and cash equivalents
cash	36,307	1,161	-130,269	120,004	21,872	8,881	203	-314	-257	-121	-116,354	111,701	-27,518	32,863	0
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	36,307	1,161	-130,269	120,004	21,872	8,881	203	-314	-257	-121	-116,354	111,701	-27,518	32,863	0

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for hale international(uk) limited. Get real-time insights into hale international(uk) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for hale international(uk) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in HA3 area or any other competitors across 12 key performance metrics.

HALE INTERNATIONAL(UK) LIMITED group structure

Hale International(Uk) Limited has 1 subsidiary company.

Ultimate parent company

SJ PHARMACARE LIMITED

11442313

1 parent

HALE INTERNATIONAL(UK) LIMITED

07011593

1 subsidiary

HALE PHARMACY LIMITED

05673613

HALE INTERNATIONAL(UK) LIMITED Shareholders

sj pharmacare ltd

100%

Hale International(Uk) Limited currently has 2 directors. The longest serving directors include Mr Jayvin Patel (Feb 2019) and Mrs Shree Patel (Feb 2019).

officer	country	age	start	end	role
Mr Jayvin Patel	England	36 years	Feb 2019	-	Director
Mrs Shree Patel	England	35 years	Feb 2019	-	Director

P&L

April 2024

turnover

211.7k

-3%

operating profit

10k

gross margin

27.1%

-3.35%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2024

net assets

31.4k

+0.4%

total assets

328.6k

-0.02%

cash

58.2k

+1.66%

net assets

Total assets minus all liabilities

Similar Companies

3.5

3.5

evergreen pharma limited

4.5

company number

07011593

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

September 2009

ultimate parent company

SJ PHARMACARE LIMITED

previous names

N/A

address

hillingdon house, 386-388 kenton road, harrow, middlesex, HA3 9DP

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to hale international(uk) limited. Currently there are 3 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for HALE INTERNATIONAL(UK) LIMITED. This can take several minutes, an email will notify you when this has completed.

hale international(uk) limited Company Information

hale international(uk) limited Estimated Valuation

hale international(uk) limited Estimated Valuation

hale international(uk) limited Estimated Valuation

Hale International(uk) Limited Overview

Hale International(uk) Limited Health Check

HALE INTERNATIONAL(UK) LIMITED financials

hale international(uk) limited Credit Report and Business Information

Hale International(uk) Limited Competitor Analysis

hale international(uk) limited Ownership

hale international(uk) limited directors

hale international(uk) limited company details

hale international(uk) limited Charges & Mortgages

hale international(uk) limited Capital Raised & Share Issues BETA

hale international(uk) limited Companies House Filings - See Documents